Week10, 2024
1. Influenza activity remains elevated nationally, increasing in some regions, with 15.4% of clinical specimens testing positive for influenza this week.
2. Influenza A and B viruses were reported in clinical labs at 54.4% and 45.6%, respectively, and public health labs reported 66.8% Influenza A and 33.2% Influenza B.
3. Influenza A(H1N1)pdm09 (54.7%) and A(H3N2) (45.3%) were nearly evenly distributed among subtyped Influenza A viruses this week.
4. Outpatient visits for influenza-like illness (ILI) accounted for 3.7%, slightly decreased from the previous week but still above the national baseline, with high or very high activity in 16 jurisdictions.
5. Cumulative influenza hospitalization rate is 67.9 per 100,000, predominantly affecting adults aged 65+ and younger children.
6. Influenza-associated hospitalizations totaled 8,819 this week, marking a continued overall decline since January.
7. Pediatric deaths increased, with 13 new deaths this season, bringing the total to 116; most were linked to Influenza A.
8. Antiviral resistance remains low; however, a few isolated cases of reduced susceptibility to oseltamivir, peramivir, and baloxavir were noted in Influenza A viruses.
9. CDC estimates 29 million illnesses, 320,000 hospitalizations, and 20,000 deaths from flu so far this season.
10. Vaccination remains recommended; flu vaccines continue to match circulating strains effectively and provide benefits.
11. Flu, RSV, and COVID-19 contribute simultaneously to respiratory illness trends; COVID-19 surveillance is integrated into these updates.
12. Regional differences were observed in influenza positivity, with some regions decreasing while others remain stable or increasing.
13. Respiratory illness visits, as well as influenza-related hospitalizations and deaths, indicate persistent activity, heavily impacting vulnerable populations.